Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.6700 (2.06%) ($8.6700 - $8.6700) on Thu. Apr. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 64 | Latest Price | $8.6700(2.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(29%) CEMB(23%) BND(21%) BWX(21%) VWO(21%) | Factors Impacting BCRX price | BCRX will decline at least -1.64% in a week (0% probabilities). VIXM(-20%) VXX(-17%) UUP(-12%) TLT(-10%) VCIT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.43(2.85%) | 10 Day Moving Average | $8.47(2.36%) | 20 Day Moving Average | $8.34(3.96%) | To recent high | -26.8% | To recent low | 9.3% | Market Cap | $1.53b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |